Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1) (INFAST)

Clinical Trial ID NCT00844805

Rank	Title	Journal	Year	PubWeight™‹?›
1	Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1.	Ann Rheum Dis	2013	2.32
2	Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2.	Ann Rheum Dis	2013	0.90